RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 76 filers reported holding RECRO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,000 | 0.0% | 1,790 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | +25.0% | 1,790 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -73.3% | 1,790 | -44.3% | 0.00% | – |
| Q2 2020 | $15,000 | -44.4% | 3,212 | -4.2% | 0.00% | – |
| Q1 2020 | $27,000 | -64.9% | 3,352 | -20.5% | 0.00% | – |
| Q4 2019 | $77,000 | +126.5% | 4,214 | +36.2% | 0.00% | – |
| Q3 2019 | $34,000 | +13.3% | 3,093 | 0.0% | 0.00% | – |
| Q2 2019 | $30,000 | +66.7% | 3,093 | 0.0% | 0.00% | – |
| Q1 2019 | $18,000 | -18.2% | 3,093 | 0.0% | 0.00% | – |
| Q4 2018 | $22,000 | 0.0% | 3,093 | 0.0% | 0.00% | – |
| Q3 2018 | $22,000 | +120.0% | 3,093 | +52.7% | 0.00% | – |
| Q2 2018 | $10,000 | -54.5% | 2,026 | 0.0% | 0.00% | – |
| Q1 2018 | $22,000 | +15.8% | 2,026 | 0.0% | 0.00% | – |
| Q4 2017 | $19,000 | +5.6% | 2,026 | 0.0% | 0.00% | – |
| Q3 2017 | $18,000 | +28.6% | 2,026 | 0.0% | 0.00% | – |
| Q2 2017 | $14,000 | – | 2,026 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
| First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
| AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
| Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
| HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
| Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
| Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
| TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
| ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |